145
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm

, , ORCID Icon, , &
Pages 739-745 | Published online: 29 Apr 2021

References

  • Thrall G, Lane D, Carroll D, Lip GYH. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119:448–e1. doi:10.1016/j.amjmed.2005.10.057
  • Boriani G, Laroche C, Diemberger I, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF pilot general registry. Am J Med. 2015;128:509–518. doi:10.1016/j.amjmed.2014.11.02625534423
  • Bakhai A, Darius H, De Caterina R, et al. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry. Eur Hear J - Qual Care Clin Outcomes. 2016;2:299–305. doi:10.1093/ehjqcco/qcw031
  • Freeman JV, Simon DN, Go AS, et al. Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes. 2015;8:393–402. doi:10.1161/CIRCOUTCOMES.114.00130326058720
  • Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German atrial fibrillation competence NETwork and the European heart rhythm association. Europace. 2007;9:1006–1023. doi:10.1093/europace/eum19117897925
  • Wynn GJ, Todd DM, Webber M, et al. The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification. Europace. 2014;16:965–972. doi:10.1093/europace/eut39524534264
  • Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.27567408
  • Witassek F, Springer A, Adam L, et al. Health-related quality of life in patients with atrial fibrillation: the role of symptoms, comorbidities, and the type of atrial fibrillation. PLoS One. 2019;14:1–14. doi:10.1371/journal.pone.0226730
  • Chatterjee S, Sardar P, Lichstein E, Mukherjee D, Aikat S. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. PACE - Pacing Clin Electrophysiol. 2013;36:122–133. doi:10.1111/j.1540-8159.2012.03513.x22978656
  • Al-Khatib SM, Allen LaPointe NM, Chatterjee R, et al. Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2014;160:760–773. doi:10.7326/M13-146724887617
  • Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA - J Am Med Assoc. 2019;321:1261–1274. doi:10.1001/jama.2019.0693
  • Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383:1305–1316. doi:10.1056/NEJMoa201942232865375
  • Grönefeld GC, Lilienthal J, Kuck KH, Hohnloser SH. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: results from a prospective randomized study. Eur Heart J. 2003;24:1430–1436. doi:10.1016/S0195-668X(03)00261-612909072
  • Pepine CJ. Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials. Clin Med Insights Cardiol. 2013;7:1–20. doi:10.4137/CMC.S1062823400444
  • Jenkins LS, Brodsky M, Schron E, et al. Quality of life in atrial fibrillation: the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Am Heart J. 2005;149:112–120.15660042
  • Rienstra M, Lubitz SA, Mahida S, et al. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012;125:2933–2943. doi:10.1161/CIRCULATIONAHA.111.06945022689930
  • Alegret JM, Viñolas X, Martínez-Rubio A, et al. Gender differences in patients with atrial fibrillation undergoing electrical cardioversion. J Women’s Heal. 2015;24:466–470. doi:10.1089/jwh.2014.5014
  • Ha ACT, Breithardt G, Camm AJ, et al. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (registry on cardiac rhythm disorders assessing the control of atrial fibrillation: REC. Circ Cardiovasc Qual Outcomes. 2014;7:896–904. doi:10.1161/HCQ.000000000000001125387780
  • Hagens VE, Ranchor AV, Van Sonderen E, et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: results from the rate control versus electrical cardioversion (RACE) study. J Am Coll Cardiol. 2004;43:241–247. doi:10.1016/j.jacc.2003.08.03714736444
  • Steg PG, Alam S, Chiang C-E, et al. Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart. 2012;98(3):195–201. doi:10.1136/heartjnl-2011-30055021948959
  • Mark DB, Anstrom KJ, Sheng S, et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA - J Am Med Assoc. 2019;321:1275–1285. doi:10.1001/jama.2019.0692
  • Pokorney SD, Kim S, Thomas L, Fonarow GC, Kowey PR. Cardioversion and subsequent quality of life and natural history of atrial fibrillation. Am Heart J. 2017;185:59–66. doi:10.1016/j.ahj.2016.10.01828267476
  • Szymanski FM, Filipiak KJ, Karpinski G, Platek AE, Opolski G. Occurrence of poor sleep quality in atrial fibrillation patients according to the EHRA score. Acta Cardiol. 2014;69:291–296. doi:10.1080/AC.69.3.302783225029874
  • Kotecha D, Chudasama R, Lane DA, Kirchhof P, Lip GYH. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol. 2016;15:660–666. doi:10.1016/j.ijcard.2015.10.220
  • Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250–3257. doi:10.1093/eurheartj/ehv51326419625
  • Björkenheim A, Brandes A, Magnuson A, et al. Assessment of atrial fibrillation–specific symptoms before and 2 years after atrial fibrillation ablation: do patients and physicians differ in their perception of symptom relief? JACC Clin Electrophysiol. 2017;3:1168–1176. doi:10.1016/j.jacep.2017.04.00329759501